SaneVax, Inc.

Safe, Affordable, Necessary & Effective Vaccines and Vaccination Practices

HHS Launches New Consumer-Focused Immunization Website

By Leave a Comment

WASHINGTON–(BUSINESS WIRE)–The U.S. Department of Health and Human Services today unveiled an innovative new website to help parents and other consumers learn about the most effective way to protect themselves and their children from infectious diseases and learn about immunization. Vaccines.gov brings together the best in federal resources on vaccine and immunizations to provide consumers […]

[Continue reading...]

Interview with Dr. Suzanne Humphries

By Leave a Comment

By the Health Ranger Video Information In this interview, you’ll hear Dr Humphries talk about vaccines, including: * Why she became concerned about vaccines after noticing kidney failure in patients who recently received vaccines. * Why vaccines are often contaminated with unknown viral strains, and why the vaccine industry has covered up known vaccine contamination […]

[Continue reading...]

Vaccine Excipients and Media Summary

By

Excipients are inactive ingredients of a drug product necessary for production of a finished pharmaceutical formulation. Growth media are culture materials used to produce mass quantities of micro-organism antibodym, or other immunologic agent, suitable for further processing into a pharmaceutical. Below is a summary of the excipients and culture media included in most vaccines licensed […]

[Continue reading...]

Aluminum Hydroxide Injections Lead to Motor Deficits and Motor Neuron Degeneration

By

Authors:  Christopher Shaw/Michael Petrik 10 Feb 2010 Abstract:  Gulf War Syndrome is a multi-system disorder afflicting many veterans of Western armies in the 1990–1991 Gulf War. A number of those afflicted may show neurological deficits including various cognitive dysfunctions and motor neuron disease, the latter expression virtually indistinguishable from classical amyotrophic lateral sclerosis (ALS) except […]

[Continue reading...]

Cervarix: Food and Drug Administration

By

Proper Name: Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant Tradename: Cervarix Manufacturer: GlaxoSmithKline Biologicals 16 October 2009, Cervarix® was approved for use in the United States, by the FDA. To examine all available FDA documents pertaining to the approval of this HPV vaccine visit the two FDA links below. Proper Name: Human Papillomavirus […]

[Continue reading...]

PATIENT INFORMATION ABOUT GARDASIL

By

What important information about GARDASIL should I know? You should continue to get routine cervical cancer screening. GARDASIL may not fully protect everyone who gets the vaccine. GARDASIL will not protect against HPV types that you already have.   Who should not get GARDASIL? You should not get GARDASIL if you have, or have had: […]

[Continue reading...]

Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients

By

This study is currently recruiting participants. Verified by University of Alberta, February 2010 Official Title Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients Purpose Human papillomavirus (HPV) affects a significant number of transplant patients. In women, human papillomavirus (HPV) causes genital warts, pre-cancerous areas of the cervix, and cervical cancer. […]

[Continue reading...]

Preparing for Adolescent HIV Vaccine Trials in South Africa: (CATSA)

By

This study is not yet open for participant recruitment. Verified by Desmond Tutu HIV Centre, July 2009 Official Title Preparing for Adolescent HIV Vaccine Trials in South Africa: a Multi-centre Study to Evaluate Acceptability of the HPV Vaccine in Adolescents Purpose This study will use the licensed HPV vaccine, Gardasil, as a surrogate for an […]

[Continue reading...]

Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India

By

This study has been suspended. (Temporarily suspended: waiting for Indian Governement clearance ) Official Title Randomised Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India Purpose The primary study hypothesis is that a two-dose human papillomavirus (HPV) vaccine regimen would offer similar immunogenicity and protection as that of a three-dose regimen […]

[Continue reading...]

Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting

By

This study is not yet open for participant recruitment. Verified by University of Pittsburgh, August 2010 Official Title  Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting Purpose The investigators propose a randomized, open label trial of the immunogenicity of HPV vaccine among males 18-24 years old, comparing an on-time administration […]

[Continue reading...]

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease

By

This study is currently recruiting participants. Verified by Mayo Clinic, July 2010 Official Title: Comparison of Immune Response to the Human Papillomavirus Vaccine in Young Women With and Without Inflammatory Bowel Disease Purpose The Gardasil vaccine, a vaccine targeted towards the human papillomavirus (HPV), has been shown to prevent the transmission of several strains of […]

[Continue reading...]

GARDASIL Reexamination Study

By

This study is currently recruiting participants. Verified by Merck, February 2010 Official Title Re-examination Study for General Vaccine Use to Assess the Safety Profile of GARDASIL in Usual Practice Purpose This survey is conducted for preparing application materials for re-examination under the Pharmaceutical Affairs Laws and its Enforcement Regulation, its aim is to reconfirm the […]

[Continue reading...]

News

Videos

Contact